Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6626
Upexi
UPXI
$90.3M
| $21.3K | ﹤0.01% |
27,166
+20,066
| +283% | +$23.3K |
2025 Q1
5 quarters
|
|
6627
Cue Biopharma
CUE
$201M
| $21.3K | ﹤0.01% |
674
+62
| +10% | +$1.4K |
2018 Q1
33 quarters
|
|
6628
First Guaranty Bancshares
FGBI
$138M
| $21.2K | ﹤0.01% |
2,109
-86
| -4% | -$827 |
2015 Q4
42 quarters
|
|
|
CANG
6629
Cango Inc
CANG
$144M
| $21.2K | ﹤0.01% |
10,379
+1,107
| +12% | +$4.57K |
2020 Q3
23 quarters
|
|
|
FLZH
6630
DELISTED
FLASH SPORTS & MEDIA HLDG
FLZH
| $21.2K | ﹤0.01% |
11,165
+11,137
| +39,775% | +$76.9K |
2021 Q1
21 quarters
|
|
6631
Cumberland Pharmaceuticals
CPIX
$105M
| $21.1K | ﹤0.01% |
3,261
+1
| +0% | +$5 |
2013 Q2
52 quarters
|
|
6632
IceCure Medical
ICCM
$5.1M
| $21.1K | ﹤0.01% |
4,334
+3,767
| +664% | +$27.2K |
2023 Q4
10 quarters
|
|
6633
DeFi Development Corp
DFDV
$147M
| $21.1K | ﹤0.01% |
7,162
-16,397
| -70% | -$62.8K |
2025 Q2
4 quarters
|
|
6634
Aptera Motors
SEV
$67.1M
| $21K | ﹤0.01% |
8,575
+5,000
| +140% | +$12.8K |
2025 Q4
2 quarters
|
|
6635
Coffee Holding Co
JVA
$26.4M
| $20.9K | ﹤0.01% |
6,264
+2,001
| +47% | +$8.47K |
2013 Q2
52 quarters
|
|
6636
Franklin FTSE Germany ETF
FLGR
$36.6M
| $20.9K | ﹤0.01% |
648
-129,261
| -100% | -$4.29M |
2023 Q4
10 quarters
|
|
6637
DFA Real Estate Securities Portfolio ETF Class Shares
DFAR
$1.65B
| $20.9K | ﹤0.01% |
797
| – | – |
2022 Q4
14 quarters
|
|
6638
Veru
VERU
$41.9M
| $20.9K | ﹤0.01% |
6,662
+2,415
| +57% | +$6.15K |
2019 Q2
28 quarters
|
|
6639
Vanguard New York Tax-Exempt Bond ETF
MUNY
$477M
| $20.8K | ﹤0.01% |
200
+199
| +19,900% | +$20.5K |
2026 Q1
1 quarter
|
|
6640
Cineverse
CNVS
$45.4M
| $20.8K | ﹤0.01% |
7,000
| – | – |
2021 Q2
20 quarters
|
|
6641
Revolution Medicines Inc Warrant
RVMDW
$108M
| $20.8K | ﹤0.01% |
2,216
| – | – |
2026 Q1
1 quarter
|
|
6642
Scage Future
SCAG
$13.7M
| $20.8K | ﹤0.01% |
+40,000
| New | +$29.5K |
2026 Q2
0 quarters
|
|
6643
First Trust Latin America AlphaDEX Fund
FLN
$48.5M
| $20.8K | ﹤0.01% |
839
+662
| +374% | +$17.3K |
2013 Q2
52 quarters
|
|
6644
Aprea Therapeutics
APRE
$7.61M
| $20.7K | ﹤0.01% |
25,830
+3,500
| +16% | +$2.92K |
2019 Q4
26 quarters
|
|
6645
Relative Sentiment Tactical Allocation ETF
MOOD
$154M
| $20.7K | ﹤0.01% |
475
| – | – |
2024 Q2
8 quarters
|
|
6646
Oncolytics Biotech
ONCY
$73M
| $20.7K | ﹤0.01% |
21,765
-6,222
| -22% | -$5.77K |
2018 Q2
32 quarters
|
|
6647
DELISTED
Smart Powerr
CREG
| $20.6K | ﹤0.01% |
+10,000
| New | +$42.3K |
2026 Q2
0 quarters
|
|
6648
United States Gasoline Fund
UGA
$190M
| $20.6K | ﹤0.01% |
200
-1,760
| -90% | -$191K |
2013 Q2
52 quarters
|
|
6649
Connect Biopharma Holdings
CNTB
$54.8M
| $20.6K | ﹤0.01% |
8,639
+5,049
| +141% | +$12.2K |
2025 Q2
4 quarters
|
|
6650
Vanguard Multi-Sector Income Bond ETF
VGMS
$266M
| $20.5K | ﹤0.01% |
400
| – | – |
2025 Q4
2 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.